India

Delhi High Court Dismisses Plea for Mandatory Disclosure of Drug Side Effects by Doctors

The Delhi High Court has dismissed a plea seeking a directive requiring medical professionals to explicitly state all potential risks and side effects of medicines or pharmaceutical drugs when administered to a patient. The division bench, consisting of Acting Chief Justice Manmohan Singh and Justice Manmeet Pritam Singh Arora, referred to the Drugs and Cosmetics Act of 1945, which mandates drug manufacturers or their agents to provide package inserts detailing the side effects to consumers and pharmacies.

The bench stated that since the legislature has assigned this responsibility to manufacturers and pharmacists, the court cannot issue the directions sought in the Public Interest Litigation (PIL) as it would be tantamount to judicial overreach.

PIL Rejected

The bench highlighted that the petitioner did not dispute the adequacy of the information provided by manufacturers through inserts accompanying medicines sold by registered pharmacists. However, the petitioner contended that if doctors included this information alongside their prescriptions, patients and caregivers could make informed choices with valid consent. The court noted that the legislature had intentionally placed this duty on manufacturers and pharmacists, leaving no grounds for the court to issue the directions requested in the PIL. Since the PIL acknowledged that there was no regulatory gap, the court concluded that the requested directions could not be granted. Consequently, the PIL and associated applications were dismissed.

Also read: Lok Sabha Elections Phase 5: 56.68% Voter Turnout by 5 PM, West Bengal Tops with 73%

Petitioner’s Argument

The PIL was filed by Jacob Vadakanchery, who argued that medicines can have severe side effects and that patients have a right to make informed choices. He asserted that it should be mandatory for prescribing doctors to inform patients about these side effects. Vadakanchery claimed that prescribing medicine without detailing potential side effects does not constitute obtaining valid consent from the patient. He urged for the responsibility to shift from manufacturers and pharmacists to medical practitioners to ensure patients are properly informed.

Kavya Bhatt

Recent Posts

From Apples To Saffron: PM Modi Celebrates India’s Agricultural Innovations

PM Modi praised India’s environmental achievements and the 'Ek Ped Maa Ke Naam' initiative during…

2 mins ago

Market Outlook For Next Week: Key Domestic And Global Cues To Watch

Next week, several major companies, including Adani Green, Adani Total Gas, KPIT Tech, TVS Motors,…

5 mins ago

Hrithik Roshan And Saba Azad Enjoy Cosy Lunch Date In The US With Sophie Choudry

Hrithik Roshan flew to the US to attend a fan meet-and-greet event as part of…

20 mins ago

PM Modi Honors Dr Kasturirangan’s Visionary Contributions To ISRO & Education

In the 121st episode of Mann Ki Baat, PM Modi honoured Dr Kasturirangan for his…

2 hours ago

PM Modi Condemns Pahalgam Terror Attack In Mann Ki Baat; Vows Harshest Response

PM Modi reaffirmed that justice would be served and emphasised national unity in the fight…

3 hours ago

Eze and Sarr Fire Crystal Palace Into First FA Cup Final in Nine Years

Crystal Palace stormed into their first FA Cup Final in nearly a decade with an…

4 hours ago